Symposium 3: Therapeutic Drug Monitoring of Biologics in Immune Mediated Inflammatory Diseases: Reflections for the Present and Future

Monday September 14, 1300-1400 (UTC)

Konstantinos Papamichail, Harvard Medical School, USA
Michael Wiese, University of South Australia, Australia

Learning Objectives: At the end of this session participants will be able to:
- Discuss the role of reactive therapeutic drug monitoring (TDM) of biologics in patients with inflammatory bowel disease (IBD).
- Discuss the role of proactive TDM of biologics in patients with IBD.
- Identify the knowledge gaps regarding the utilization of TDM of biologics in IBD.

Question Title

* 1. This session overall

	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree

Comments:

Question Title

* 2. Overall, I would rate this symposium as:

Fair

Good

Excellent

Comments

Question Title

* 3. Speaker: Konstantinos Papamichail

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 4. Speaker: Michael Wiese

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 5. As a result of attending this session, I am planning to:

a) Discuss the session with my colleagues.

b) Pursue additional learning activities.

c) Create/revise protocols, policies, and/or procedures.

d) Not change my practice.

Symposium 3: Therapeutic Drug Monitoring of Biologics in Immune Mediated Inflammatory Diseases: Reflections for the Present and Future

Monday September 14, 1300-1400 (UTC)

Question Title

* 1. This session overall

Question Title

* 2. Overall, I would rate this symposium as:

Question Title

* 3. Speaker: Konstantinos Papamichail

Question Title

* 4. Speaker: Michael Wiese

Question Title

* 5. As a result of attending this session, I am planning to:

Question Title

* 6. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 7. What topics would you like to be addressed at future conferences to keep you up to date in your profession?